Article révisé par les pairs
Titre:
  • Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study.
Auteur:de Azambuja, Evandro; Paesmans, Marianne; Beauduin, Marc; Vindevoghel, Anita; Cornez, Nathalie; Finet, Claude; Ries, Fernand; Closon-Dejardin, Marie Thérèse; Kerger, Joseph; Gobert, Philippe; Focan, Christian; Tagnon, Alain; Dolci, Stella; Nogaret, Jean-Marie; Di Leo, Angelo; Piccart-Gebhart, Martine
Informations sur la publication:Journal of clinical oncology, 27, 5, page (720-725)
Statut de publication:Publié, 2009-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antibiotics, Antineoplastic -- administration & dosage
Antineoplastic Agents, Alkylating -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Belgium
Breast Neoplasms -- drug therapy
Breast Neoplasms -- mortality
Breast Neoplasms -- pathology
Chemotherapy, Adjuvant
Cyclophosphamide -- administration & dosage
Disease-Free Survival
Epirubicin -- administration & dosage
Female
Fluorouracil
Humans
Lymph Nodes -- pathology
Methotrexate
Middle Aged
Note générale:Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2008.17.2155
info:pii/JCO.2008.17.2155
info:scp/59949088631
info:pmid/19103732

Documents en relation

DI-fusion